{
  "id": 7671393,
  "title": "Hinge Health exec. chairman Gabriel Mecklenburg sells $13.98m in stock",
  "url": "https://urgent.news/2026/09/16/hinge-health-exec-chairman-gabriel-mecklenburg-sells-13-98m-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-16T01:01:07.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/hinge-health-exec-chairman-gabriel-mecklenburg-sells-1398m-in-stock-93CH-4902812"
  },
  "original_language": "en",
  "account": "Hinge Health's Executive Chairman, Gabriel Mecklenburg, sold shares worth approximately $13.98 million on September 14, 2026. The sale involved converting 150,000 Class B shares into an equivalent amount of Class A shares, which were then sold at prices between $88.9793 and $94.7033 per share. Mecklenburg holds a total of 3,920,306 shares of Class B Common Stock, convertible into Class A shares, with direct holdings of 1,844,004 shares, and indirect holdings of 383,592 and 692,710 shares through trust arrangements. The transaction was executed in accordance with a pre-approved Rule 10b5-1 trading plan. Hinge Health's stock price is near its 52-week high of $95.57, following a 113% increase over six months, but is currently deemed overvalued according to InvestingPro analysis. The company reported strong second-quarter earnings for 2026, surpassing expectations with earnings of $0.59 per share and revenue of $212.8 million, marking a 53% increase. Hinge Health has also raised its full-year revenue and profit guidance, expanding into new areas like migraine and gastrointestinal care, and is set to acquire Cylinder Health for $105 million. Analysts have responded positively to these developments, with price targets ranging from $107 to $115.",
  "summary": null,
  "key_points": [
    "Hinge Health CEO Gabriel Mecklenburg sold $13.98m in stock on Sep 14, 2026",
    "Mecklenburg converted 150k Class B shares to Class A, selling at $88.98-$94.70 per share",
    "Sale executed via pre-approved Rule 10b5-1 plan, stock near 52-week high"
  ],
  "editors_take": "Gabriel Mecklenburg's sale of $13.98 million in Hinge Health stock comes as the company's shares are near a 52-week high and deemed overvalued, potentially signalling a strategic repositioning by a key insider.",
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Cathie Wood’s ARK buys Guardant Health stock, sells Iridium",
        "url": "https://urgent.news/2026/09/16/cathie-woods-ark-buys-guardant-health-stock-sells-iridium",
        "published": "2026-09-16T00:04:47.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}